References
Kuppachi S, Idris N, Chander PN, Yoo J (2006) Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker–case report, review of literature. Nephrol Dial Transplant 21(12):3571–3575
Wu L, Juurlink BH (2002) Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39(3):809–14
Miyata T, de Strihou C, Ueda Y, Ichimori K, Inagi R, Onogi H, Ishikawa N, Nangaku M, Kurokawa K (2002) Angiotensin II receptor antagonists, angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 13(10):2478–2487
Geroldi D, Falcone C, Emanuele E, D’Angelo A, Calcagnino M, Buzzi MP, Scioli GA, Fogari R (2005) Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens 23:1725–1729
Williams B (1998) A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? Miner Electrolyte Metab 24(6):400–405
Yoshimura M, Kida H, Saito Y, Yokoyama H, Tomosugi N, Abe T, Hattori N (1985) Peculiar glomerular lesions in Takayasu’s arteritis. Clin Nephrol 24(3):120–127
Zhou XJ, Saxena R, Liu Z, Vaziri ND (2008) Silva FG: renal senescence in 2008: progress and challenges. Int Urol Nephrol 40:823–839
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasmani, R., Thiyagarajan, T., Narwal-Chadha, R. et al. The other end of spectrum in hypertension: ‘Idiopathic nodular glomerulosclerosis’. Int Urol Nephrol 42, 857–859 (2010). https://doi.org/10.1007/s11255-009-9614-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-009-9614-1